Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Infectious Diseases

Answer 4
  1. Discontinue treatment. The current treatment recommendations for persons with chronic HCV infection, genotype 1, is pegylated interferon plus ribavirin for 48 weeks. However, an early viral response, defined as a minimum of a 2-log decrease in viral load during the first 12 weeks of treatment, is predictive of a sustained viral response. Therefore, continuation of therapy in patients who fail to achieve this minimum response at 12 weeks is generally considered unnecessary.1

     Chronic hepatitis C: current disease management. Bethesda (MD): National Digestive Diseases Information Clearinghouse; 2002. NIH Publication No. 02-4230. Available at http://www.niddk.nih.gov/health/digest/pubs/chrnhepc/chrnhepc.htm. Accessed 2 Dec 2002.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj